Brett Kaplan

Business address
C/O Prevail Therapeutics Inc., 430 East 29 Th Street, Suite 940, New York, NY, 10016
Top holdings (ownership)
CLYM
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Brett Kaplan has filed 9 SEC EDGAR filings since 19 Jun 2019

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 4 15 Jan 2025 13 Jan 2025 001-40708
4 Open Document Open Filing 4 26 Aug 2024 26 Aug 2024 001-40708
3 Open Document Open Filing 3 26 Aug 2024 26 Aug 2024 001-40708
4 Open Document Open Filing FORM 4 SUBMISSION 23 Feb 2022 18 Feb 2022 001-39696
4 Open Document Open Filing FORM 4 SUBMISSION 26 Jan 2021 22 Jan 2021 001-38939
4 Open Document Open Filing FORM 4 SUBMISSION 14 Sep 2020 10 Sep 2020 000-55939
3 Open Document Open Filing FORM 3 SUBMISSION 14 Sep 2020 10 Sep 2020 000-55939
4 Open Document Open Filing FORM 4 SUBMISSION 11 Mar 2020 19 Feb 2020 001-38939
3 Open Document Open Filing FORM 3 SUBMISSION 19 Jun 2019 19 Jun 2019 001-38939